Abstract | BACKGROUND/AIM: PATIENTS AND METHODS: Eligible patients diagnosed within 2011-2018 with LA-NSCLC were identified via the Taiwan Cancer Registry. We used propensity-score weighting to balance observable potential confounders, and then compared the hazard ratios of death between aCCRT-treated vs. aCT-treated groups. We also performed supplementary analyses using propensityscore matching. RESULTS: Our main study population consisted of 82 patients. The propensity score weight-adjusted hazard ratio of death for the aCCRT group was 0.74 (95% confidence interval=0.35-1.56, p=0.43). There was also no statistically significant difference in survival between groups in the supplementary analyses. CONCLUSION: For patients treated with radical but R1 resection for LA-NSCLC, there was no significant OS benefit from the addition of concurrent radiotherapy.
|
Authors | Chih-Yen Tu, Hung-Jen Chen, Te-Chun Hsia, Hsin-Yuan Fang, Chia-Chin Li, Chun-Ru Chien |
Journal | Anticancer research
(Anticancer Res)
Vol. 42
Issue 6
Pg. 3195-3201
(Jun 2022)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 35641272
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. |
Topics |
- Carcinoma, Non-Small-Cell Lung
(therapy)
- Chemoradiotherapy, Adjuvant
- Chemotherapy, Adjuvant
- Cohort Studies
- Humans
- Lung Neoplasms
(therapy)
- Margins of Excision
|